Free-cash-flow proxy decreased 87.6%
Free-cash-flow proxy changed -87.6% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$82.5M→$10.2M3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →TMDX financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow decreased 81.1%
Operating cash flow changed -81.1% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$91.6M→$17.3M3 prior comparisons
Current ratio decreased 32.8%
Current ratio changed -32.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
9.86→6.624 prior comparisons
Working capital / assets moved 1856 bp lower
Working capital / assets changed -1856 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
56.32%→37.75%4 prior comparisons
Operating income decreased 35.1%
Operating income changed -35.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$36.6M→$23.7M2 prior comparisons
Operating margin moved 1074 bp lower
Operating margin changed -1074 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
23.24%→12.50%2 prior comparisons
Total assets increased 64.4%
Total assets changed +64.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$890.5M→$1.5B4 prior comparisons
Research & development increased 98.5%
Research & development changed +98.5% from the comparable as-filed period.
$15.9M→$31.6M2 prior comparisons
Inventory / revenue moved 380 bp higher
Inventory / revenue changed +380 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
24.70%→28.50%2 prior comparisons
Revenue increased 20.7%
Revenue changed +20.7% from the comparable as-filed period.
$157.4M→$189.9M2 prior comparisons
Selling, general & administrative increased 31.2%
Selling, general & administrative changed +31.2% from the comparable as-filed period.
$44.1M→$57.8M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.